Audiometry-Confirmed Sudden Sensorineural Hearing Loss Incidence among COVID-19 Patients and BNT162b2 Vaccine Recipients.

Otol Neurotol

Department of Otolaryngology-Head and Neck Surgery, Samson Assuta Ashdod University Hospital, Ashdod, Israel and Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er Sheva, Israel.

Published: February 2023

Objective: To compare sudden sensorineural hearing loss (SSNHL) incidence rates over the coronavirus disease 2019 (COVID-19) outbreak and the COVID-19 vaccination campaign periods to pre-COVID-19 periods.

Study Design: Retrospective cohort.

Setting: Secondary hospital.

Patients: Patients >12 years with auditory-confirmed SSNHL were enrolled. COVID-19 status and BNT162 inoculation records ≤28 days before SSNHL diagnosis were retrieved. Patients were categorized according to their date of presentation over four equal periods: 1) July 2018-April 2019 (first prepandemic period), 2) May 2019-February 2020 (second prepandemic period), 3) March 2020-December 2020 (COVID-19 outbreak), and 4) January 2021-October 2021 (BNT162b2 vaccinations campaign).

Interventions: Pre- and post-COVID-19 emergence; BNT162b2 vaccine.

Main Outcome Measures: Incidence rate ratios (IRRs) were calculated to compare SSNHL cases during the COVID-19 and vaccination periods with pre-COVID-19 periods.

Results: Of the 100 patients with SSNHL over the four periods, 1 had COVID-19 and 8 were vaccinated. The annual SSNHL incidence was 12.87, 12.28, 13.45, and 19.89 per 100,000 over periods 1 to 4, respectively. SSNHL incidence over the third period was not significantly different than the first/second periods (IRR = 1.045, 95% confidence interval [CI] = 0.629-1.85, ρ = 0.788, and IRR = 1.095, 95% CI = 0.651-1.936, ρ = 0.683, respectively), whereas SSNHL incidence rate over the fourth period was higher (IRR = 1.545, 95% CI = 0.967-2.607, ρ = 0.068, and IRR = 1.619, 95% CI = 1-2.73, ρ = 0.05, respectively). SSNHL incidence in vaccine recipients was lower than prepandemic unvaccinated patients (IRR = 0.584, 95% CI =0.464-1.67, ρ = 0.984, and IRR = 0.612, 95% CI =0.48-1.744, ρ = 0.92, respectively).

Conclusion: There were fewer SSNHL cases during the first COVID-19 months. Although the SSNHL rate over the COVID-19 vaccination campaign increased, it was not higher for patients who received the BNT162b2 vaccine.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835237PMC
http://dx.doi.org/10.1097/MAO.0000000000003777DOI Listing

Publication Analysis

Top Keywords

ssnhl incidence
20
covid-19 vaccination
12
ssnhl
11
covid-19
9
sudden sensorineural
8
sensorineural hearing
8
hearing loss
8
bnt162b2 vaccine
8
vaccine recipients
8
covid-19 outbreak
8

Similar Publications

Spontaneous Hearing Recovery Two Years Following Onset of Bilateral Sudden Sensorineural Hearing Loss: Miracle May Happen any Time.

Mymensingh Med J

January 2025

Dr Md Harun Ar Rashid Talukder, Associate Professor (Otology), Department of Otolaryngology-Head & Neck Surgery, BSMMU, Dhaka, Bangladesh, Dhaka, Bangladesh; E-mail:

Sudden sensorineural hearing loss is a medical emergency. Incidence is very low. Unilateral SSNHL is common and mostly idiopathic.

View Article and Find Full Text PDF

Purpose: Benzodiazepine receptor agonists (BZRAs), including benzodiazepines (BZDs) and Z drugs, are widely prescribed for anxiety and sleep. Therefore, issues of tolerance, dependence and adverse effects are of concern. Recent studies suggested a potential link between BZRAs and hearing problems.

View Article and Find Full Text PDF

Metformin lowers risk of hearing loss and mortality in type 2 diabetes.

Diabetes Obes Metab

December 2024

Department of Otorhinolaryngology, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan.

Aims: To assess the association between metformin use and the risk of sudden sensorineural hearing loss (SSNHL) in patients with Type 2 diabetes (T2D), a population at elevated risk for SSNHL.

Materials And Methods: This cohort study utilized data from Taiwan's National Health Insurance Research Database, following T2D patients from 2008 to 202 database's baseline. Metformin use was defined as achieving ≥80% of the medication possession ratio (MPR) and ≥28 cumulative defined daily doses (cDDD) within three months.

View Article and Find Full Text PDF

The Predictive Value of NLR, PLR and SII for SSNHL in Children and Young Adults.

Indian J Otolaryngol Head Neck Surg

December 2024

ENT Department, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang, Hubei China.

Unlabelled: Sudden Sensorineural Hearing Loss is a common emergency in otolaryngology, with an increasing incidence among younger age groups. This study retrospectively analyzes peripheral blood inflammatory markers in SSNHL patients under 24 years-old to explore the potential prognostic value of the immune inflammatory response in young SSNHL patients. This retrospective analysis included 53 SSNHL patients who received treatment from January 2016 to December 2023.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the connection between sudden sensorineural hearing loss (SSNHL) and various cholesterol levels (TC, TG, HDL-C, LDL-C).
  • Significant findings indicate that high total cholesterol (TC) is associated with an increased risk of SSNHL, with a confidence interval showing a strong link (95% CI, 1.34-2.91).
  • Additionally, the research highlights the importance of considering confounding factors and notes the presence of publication bias in studies linking TC levels to SSNHL prognosis.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!